S Mii1, J A Ware, K C Kent. 1. Department of Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Mass. 02215.
Abstract
BACKGROUND: Transforming growth factor-beta (TGF-beta) is released after vascular injury and may influence the healing response of the vessel wall. We investigated the effect of this growth factor on proliferation and migration of human venous smooth muscle cells (SMC) and the signal transduction mechanisms through which TGF-beta exerts this effect. METHODS: SMC derived from human saphenous vein were used in a 72-hour proliferation assay and a 6-day migration assay. Cells were exposed to TGF-beta alone and in the presence of platelet-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), epidermal growth factor, and serum. The ability of TGF-beta to activate tyrosine kinases, phosphatases, or protein kinase C was evaluated by use of Western blotting with an antiphosphotyrosine antibody. RESULTS: In a concentration-dependent manner, TGF-beta inhibited proliferation induced by PDGF, b-FGF, epidermal growth factor, and serum. This inhibitory effect was independent of SMC density. TGF-beta also inhibited migration induced by PDGF and b-FGF. Exposure of cells to TGF-beta did not lead to tyrosine phosphorylation of cellular substrates or activation of protein kinase C. CONCLUSIONS: TGF-beta inhibits both migration and proliferation of human SMC. This inhibitory effect is not mediated through protein kinase C, mitogen-activated protein kinase, or tyrosine kinases.
BACKGROUND:Transforming growth factor-beta (TGF-beta) is released after vascular injury and may influence the healing response of the vessel wall. We investigated the effect of this growth factor on proliferation and migration of human venous smooth muscle cells (SMC) and the signal transduction mechanisms through which TGF-beta exerts this effect. METHODS: SMC derived from human saphenous vein were used in a 72-hour proliferation assay and a 6-day migration assay. Cells were exposed to TGF-beta alone and in the presence of platelet-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), epidermal growth factor, and serum. The ability of TGF-beta to activate tyrosine kinases, phosphatases, or protein kinase C was evaluated by use of Western blotting with an antiphosphotyrosine antibody. RESULTS: In a concentration-dependent manner, TGF-beta inhibited proliferation induced by PDGF, b-FGF, epidermal growth factor, and serum. This inhibitory effect was independent of SMC density. TGF-beta also inhibited migration induced by PDGF and b-FGF. Exposure of cells to TGF-beta did not lead to tyrosine phosphorylation of cellular substrates or activation of protein kinase C. CONCLUSIONS:TGF-beta inhibits both migration and proliferation of human SMC. This inhibitory effect is not mediated through protein kinase C, mitogen-activated protein kinase, or tyrosine kinases.
Authors: Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent Journal: Am J Physiol Heart Circ Physiol Date: 2012-03-23 Impact factor: 4.733
Authors: Kentaro Kamiya; Kenji Sakakibara; Evan J Ryer; Raymond P Hom; Edward B Leof; K Craig Kent; Bo Liu Journal: Mol Cell Biol Date: 2007-02-26 Impact factor: 4.272
Authors: Kenneth J Furdella; Shinichi Higuchi; Kang Kim; Tom Doetschman; William R Wagner; Jonathan P Vande Geest Journal: Tissue Eng Part A Date: 2022-07 Impact factor: 4.080
Authors: George M Risinger; Dawn L Updike; Elizabeth C Bullen; James J Tomasek; Eric W Howard Journal: Am J Physiol Cell Physiol Date: 2009-10-21 Impact factor: 4.249
Authors: Shirling Tsai; Scott T Hollenbeck; Evan J Ryer; Rachel Edlin; Dai Yamanouchi; Rishi Kundi; Chunjie Wang; Bo Liu; K Craig Kent Journal: Am J Physiol Heart Circ Physiol Date: 2009-06-12 Impact factor: 4.733
Authors: Abel Martin-Garrido; Holly C Williams; Minyoung Lee; Bonnie Seidel-Rogol; Xinpei Ci; Jin-Tang Dong; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240